UK markets closed

PTC Therapeutics, Inc. (PTCT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
48.04+0.68 (+1.44%)
At close: 04:00PM EST
48.04 0.00 (0.00%)
After hours: 04:02PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
696,618
538,593
380,766
306,980
Cost of revenue
43,112
32,328
18,942
12,135
Gross profit
653,506
506,265
361,824
294,845
Operating expenses
Research development
612,646
540,684
477,643
257,452
Selling general and administrative
319,828
285,773
245,164
202,541
Total operating expenses
1,029,604
881,208
759,699
487,643
Operating income or loss
-376,098
-374,943
-397,875
-192,798
Interest expense
88,873
86,022
56,352
-
Total other income/expenses net
-71,431
-57,375
51,295
-34,637
Income before tax
-536,402
-518,340
-402,932
-239,926
Income tax expense
-5,009
5,561
35,228
11,650
Income from continuing operations
-531,393
-523,901
-438,160
-251,576
Net income
-531,393
-523,901
-438,160
-251,576
Net income available to common shareholders
-531,393
-523,901
-438,160
-251,576
Basic EPS
-
-7.43
-6.64
-4.27
Diluted EPS
-
-7.43
-6.64
-4.27
Basic average shares
-
70,466
66,028
58,863
Diluted average shares
-
70,466
66,028
58,863
EBITDA
-
-368,184
-261,708
-160,618